C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/60 (2006.01) A61K 31/435 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2131185
Disclosed herein are compounds of formula (I) wherein X is a terminal group, for exemple, an aryloxycarbonyl, an alka- noyl or an optionally mono- or disubstituted carbamoyl; B is absent or an amino acid residue,for example, Val or Asn; R1 is hy- drogen or a ring substituent, for example, fluoro or methyl; R2 is alkyl; and Y is a ring substituent, for example, phenoxy, 2-pyridinylmethoxy, phenylthio or 2-pyridinylthio. The compounds inhibit the activity of human immunodeficiency virus (HIV) protease and interfere with HIV induced cytopathogenic effects in human cells. These properties render the com- pounds useful for combating HIV infections.
Anderson Paul Cates
Beaulieu Pierre Louis
Lavallee Pierre
Soucy Francois
Yoakim Christiane
Boehringer Ingelheim (canada) Ltd. Boehringer Ingelheim (canada)
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Substituted pipecolinic acid derivatives as hiv protease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pipecolinic acid derivatives as hiv protease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pipecolinic acid derivatives as hiv protease... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1984122